Background and objective Chemotherapy is very important in the treatment of advanced non-small cell lung cancer.

背景与目的化疗在晚期非小细胞肺癌的治疗中具有极为重要的作用。

youdao

Objective: to evaluate the clinical effect and toxicity of gemcitabine monotherapy in the treatment of elder advanced non-small cell lung cancer (NSCLC).

目的观察了解吉西他滨单药治疗老年晚期非小细胞肺癌(NSCLC)的临床疗效和毒性反应。

youdao

Cisplatin and continuous infusion homemade vinorelbine combination chemotherapy for advanced Non-small cell lung cancer.

持续静脉输注国产异长春花碱加顺铂治疗晚期非小细胞肺癌临床观察。

youdao

This morning, the Food and Drug Administration announced that it had approved the AstraZeneca (nyse: AZN - news - people ) drug for treating advanced cases of non-small-cell lung cancer, which is the most common form of lung cancer in the United States.

FORBES: AstraZeneca's Big Green Light

Separately, Pfizer said that the Food and Drug Administration has approved Xalkori capsules, which the company calls the first-ever drug targeting anaplastic lymphoma kinase, or ALK, for the treatment of locally advanced or metastatic non-small cell lung cancer that is ALK-positive.

FORBES: Bristol-Myers, Pfizer Announce Positive Results; An FDA Approval for Pfizer

Most notably, we completed U.S. and Japanese filings for crizotinib in ALK-positive non-small cell lung cancer and U.S. and EU filings for axitinib in advanced renal cell carcinoma.

FORBES: Pfizer Suffers Loss Of Exclusivity, Braces Itself For Lipitor Expiration